How cannabinoids work
What is DAGL-alpha?
A simple explanation of DAGL-alpha, why cannabinoid researchers study it, and what its biology can and cannot tell us.
The short answer
Where DAGL-alpha fits into cannabinoid biology
DAGL-alpha is a biological target studied to understand how cannabinoids affect cells and signaling. Research on THC, CBC, THCV, and Endocannabinoids helps explain possible mechanisms. This page brings together 4 human-study sources, 1 research review, and 1 lab, animal, or mechanism source. The source set includes human research as well as earlier-stage studies. A mechanism alone does not prove that a cannabinoid will produce a health benefit in people. 1
Key takeaways
What to know first
- 1
Research on DAGL-alpha covers THC, CBC, and THCV; those areas should not be combined into one claim. 1
- 2
The source set includes human research as well as earlier-stage studies. 2
- 3
Dose, formulation, route, study population, and outcome can change how closely a study applies to a real-world question. 3
Research areas
What researchers studied about DAGL-alpha
These are the main questions represented in the current literature. Each link opens a source used to build the overview.
Human research included
THC
Studies examine how THC connects with DAGL-alpha or closely related target biology. These findings help explain signaling and pharmacology, not a guaranteed health effect. 2
Mostly mechanism-focused
CBC
Studies examine how CBC connects with DAGL-alpha or closely related target biology. These findings help explain signaling and pharmacology, not a guaranteed health effect. 3
Mostly mechanism-focused
THCV
Studies examine how THCV connects with DAGL-alpha or closely related target biology. These findings help explain signaling and pharmacology, not a guaranteed health effect. 4
Mostly preclinical
Endocannabinoids
Studies examine how Endocannabinoids connects with DAGL-alpha or closely related target biology. These findings help explain signaling and pharmacology, not a guaranteed health effect. 1
How strong is the research?
Not every study answers the same question
This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.
Human studies
Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.
Reviews and evidence summaries
Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.
Lab, animal, and mechanism research
Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.
What these studies actually looked at
The research on DAGL-alpha is not one kind of study. This source set includes 2 animal studies, 1 cell or laboratory study, and 1 narrative or expert review. 3
The recorded populations or models include people or patients (4 sources), animal models (1 source), and pregnancy, lactation, or reproductive context (1 source). A result from one group or model should not be assumed to apply to another. 4
The most common recorded outcome focus is endocannabinoid enzyme activity or metabolic mechanisms (3 sources), gPR119 receptor activity, binding, signaling, metabolic physiology, or pharmacology (1 source), and receptor, target, metabolic, or pharmacology mechanisms (1 source). Closely related outcome names can still describe different measurements. 5
The DAGL-alpha source set also contains findings or reviews that remain too limited, indirect, or mixed for a broad answer. That uncertainty is part of the result, not an empty space to fill with assumptions. 6
Examples from the literature
What did the studies actually look at?
Each example names the research question and the study details recorded for that source.
narrative or expert review
Potential of Fatty Acid Amide Hydrolase (FAAH), Monoacylglycerol Lipase (MAGL), and Diacylglycerol Lipase (DAGL) Enzymes as Targets for Obesity Treatment: A Narrative Review.
On this page, this source examines Endocannabinoids activity involving endocannabinoid enzyme activity or metabolic mechanisms. 1
- Study type
- narrative or expert review
- Population or model
- people or patients
- Outcome focus
- endocannabinoid enzyme activity or metabolic mechanisms
- Evidence stage
- evidence still limited
human research
Impact of tetrahydrocannabinol on the endocannabinoid 2-arachidonoylglycerol metabolism: ABHD6 and ABHD12 as novel players in human placenta.
On this page, this source examines THC activity involving endocannabinoid enzyme activity or metabolic mechanisms. 2
- Population or model
- pregnancy, lactation, or reproductive context
- Outcome focus
- endocannabinoid enzyme activity or metabolic mechanisms
- Evidence stage
- human research
cell or laboratory study
Effects of Rare Phytocannabinoids on the Endocannabinoid System of Human Keratinocytes.
On this page, this source examines CBC and skin and inflammatory dermatology. 3
- Study type
- cell or laboratory study
- Population or model
- people or patients
- Outcome focus
- skin, dermatology, antimicrobial, or topical inflammatory outcomes
- Evidence stage
- mechanism-focused research
animal study
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.
On this page, this source examines THC activity involving TRP channel activity or ionotropic cannabinoid target mechanisms, THCV activity involving receptor, target, metabolic, or pharmacology mechanisms, and THC activity involving TRPM8. 4
- Study type
- animal study
- Population or model
- people or patients
- Outcome focus
- tRP channel activity or ionotropic cannabinoid target mechanisms and receptor, target, metabolic, or pharmacology mechanisms and other recorded details
- Evidence stage
- mechanism-focused research
human research
Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer.
On this page, this source examines Endocannabinoids activity involving GPR119. 5
- Population or model
- people or patients
- Outcome focus
- gPR119 receptor activity, binding, signaling, metabolic physiology, or pharmacology
- Evidence stage
- human research
Safety and limits
What should readers keep in mind?
Research on DAGL-alpha should be read beside safety. A compound can be non-intoxicating or naturally occurring and still have pharmacologic effects, side effects, interactions, or product-quality concerns. 2
Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.
Common questions
Questions people ask
What does DAGL-alpha do?
DAGL-alpha is studied as part of cannabinoid-related biology and signaling. The exact role depends on the tissue, compound, and experimental setting. 1
Does a biological mechanism prove a health effect?
No. A mechanism can explain why an idea is plausible, but human studies are needed to test whether it changes a health outcome. 2
What research is linked to DAGL-alpha?
The main areas on this page include THC, CBC, THCV, and Endocannabinoids. The source links show the study type behind each area. 3
Sources
Read the research
The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.
-
1
Potential of Fatty Acid Amide Hydrolase (FAAH), Monoacylglycerol Lipase (MAGL), and Diacylglycerol Lipase (DAGL) Enzymes as Targets for Obesity Treatment: A Narrative Review. narrative or expert review; evidence still limited PubMed 34959715 DOI 10.3390/ph14121316
-
2
Impact of tetrahydrocannabinol on the endocannabinoid 2-arachidonoylglycerol metabolism: ABHD6 and ABHD12 as novel players in human placenta. human research PubMed 32829065 DOI 10.1016/j.bbalip.2020.158807
-
3
Effects of Rare Phytocannabinoids on the Endocannabinoid System of Human Keratinocytes. cell or laboratory study; mechanism-focused research PubMed 35628241 DOI 10.3390/ijms23105430
-
4
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. animal study; mechanism-focused research PubMed 21175579 DOI 10.1111/j.1476-5381.2010.01166.x
-
5
Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer. human research PubMed 30787385 DOI 10.1038/s41598-019-38865-4
-
6
Subcellular localization of NAPE-PLD and DAGL-α in the ventromedial nucleus of the hypothalamus by a preembedding immunogold method. animal study; preclinical research PubMed 24346263 DOI 10.1007/s00418-013-1174-x
See all 6 research sources
This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.
- Potential of Fatty Acid Amide Hydrolase (FAAH), Monoacylglycerol Lipase (MAGL), and Diacylglycerol Lipase (DAGL) Enzymes as Targets for Obesity Treatment: A Narrative Review. narrative or expert review; evidence still limited / 1 linked research note PubMed 34959715
- Subcellular localization of NAPE-PLD and DAGL-α in the ventromedial nucleus of the hypothalamus by a preembedding immunogold method. animal study; preclinical research / 1 linked research note PubMed 24346263
- Impact of tetrahydrocannabinol on the endocannabinoid 2-arachidonoylglycerol metabolism: ABHD6 and ABHD12 as novel players in human placenta. human research / 1 linked research note PubMed 32829065
- Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. animal study; mechanism-focused research / 3 linked research notes PubMed 21175579
- Effects of Rare Phytocannabinoids on the Endocannabinoid System of Human Keratinocytes. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 35628241
- Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer. human research / 1 linked research note PubMed 30787385